Trademark: 77802485
Word
STAVE- SAXAGLIPTIN TRIAL TO ASSESS VASCULAR ENDPOINTS IN DIABETES MELLITUS
Status Date
Monday, September 12, 2011
Filing Date
Wednesday, August 12, 2009
Published for Opposition
Tuesday, June 15, 2010
Abandoned Date
Monday, September 12, 2011
42 Medical and scientific research, namely, conducting clinical trials and clinical studies relating to pharmaceutical preparations for human use
"SAXAGLIPTIN TRIAL TO ASSESS VASCULAR ENDPOINTS IN DIABETES MELLITUS"
STAVE- SAXAGLIPTIN TRIAL TO ASSESS VASCULAR END POINTS IN DIABETES MELLITUS
Sep 12, 2011
Abandonment Notice Mailed - No Use Statement Filed
Sep 12, 2011
Abandonment - No Use Statement Filed
Jan 26, 2011
Notice Of Approval Of Extension Request Mailed
Jan 24, 2011
Extension 1 Granted
Jan 24, 2011
Extension 1 Filed
Jan 24, 2011
Teas Extension Received
Aug 10, 2010
Noa Mailed - Sou Required From Applicant
Jun 15, 2010
Published For Opposition
May 26, 2010
Notice Of Publication
May 12, 2010
Law Office Publication Review Completed
May 12, 2010
Assigned To Lie
May 3, 2010
Approved For Pub - Principal Register
Apr 9, 2010
Teas/Email Correspondence Entered
Apr 9, 2010
Correspondence Received In Law Office
Apr 9, 2010
Teas Response To Office Action Received
Dec 28, 2009
Attorney Revoked And/Or Appointed
Dec 28, 2009
Teas Revoke/Appoint Attorney Received
Nov 6, 2009
Non-Final Action Mailed
Nov 5, 2009
Non-Final Action Written
Oct 29, 2009
Assigned To Examiner
Aug 18, 2009
Notice Of Pseudo Mark Mailed
Aug 17, 2009
New Application Office Supplied Data Entered In Tram
Aug 15, 2009
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
